[Magnetic resonance tomography in follow-up of hydatidiform mole].
The value of magnetic resonance imaging (MRI) was studied in a case of a gestational trophoblastic tumour. In addition to the tumour size, MRI made it possible to measure necrotic areas, which are assumed to be a sign of response to chemotherapy. Moreover, uterine zonal anatomy and subserosal uterine veins yielded important information on tumour biology. Complete remission was induced in high-risk patients by etoposide, methotrexate, and actinomycin D treatment.
Marth
C
C
Univ. Klinik für Frauenheilkunde, Innsbruck.
Judmaier
W
W
Helweg
G
G
Schwegel
P
P
Wicke
K
K
Zeimet
A G
AG
Daxenbichler
G
G
Hetzel
H
H
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003609:Dactinomycin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000008:administration & dosage; D011247:Pregnancy; D014328:Trophoblastic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D014599:Uterus / Q000473:pathology
D003609:Dactinomycin; D005047:Etoposide; D002955:Leucovorin; D008727:Methotrexate
Kernspintomographie zur Verlaufskontrolle der Blasenmole.